1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. ESPERION THERAPEUTICS INC.
Esperion Therapeutics Inc.
XNAS: ESPR
3.15 0.00 (0.00%)
8.8M
XNAS Volume

XNAS 25 Jun, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Esperion Therapeutics Inc - ESPR - stock price prediction, stock price target, analyst ratings from 6 analysts

Esperion Therapeutics Inc has a share price target of US$ 3, revenue growth forecast of -16.3%, and profit growth estimate of -129.7% for FY26, based on top 6 analyst calls.